Reena Zutshi
0000-0002-2582-1484
Zan Therapeutics, LLC
25 papers found
Refreshing results…
Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype**
Diagnostic Ultrasound Combined With Glycoprotein IIb/IIIa–Targeted Microbubbles Improves Microvascular Recovery After Acute Coronary Thrombotic Occlusions
Ultrasound energy levels in the CLOTBUST trial: a step towards optimization of clinical sonothrombolysis
Composition useful for treating cancers and tumors, comprises nanodroplets having lipid defining inner area comprising compatible oil, fluorocarbon composition and active compound dispersed in aqueous medium
Application of Ultrasound to Selectively Localize Nanodroplets for Targeted Imaging and Therapy
Miniature Protein Inhibitors of the p53-hDM2 Interaction
Method, used to administer therapeutic agent, comprises supplying therapeutic agents and catheter, catheterizing blood vessel, interconnecting a container to catheter and administering prepared aqueous mixture into blood vessel
Administering stem cells to a patient, for treating Parkinson's disease or multiple myocardial infarcts, comprises administering acoustically active material and stem cells to the patient
Handheld ultrasound energy emitting device for treatment of blood clot, operates multiple ultrasound transducers simultaneously to emit ultrasound energy at one time
New modified avian pancreatic polypeptide (aPP), useful in the manufacture of a medicament for treating, e.g., inflammation, allergy, autoimmune disease, infectious disease or tumor
Non-invasive method to disrupt a blood clot within the vasculature, comprises intravascular administration of a vesicle composition comprising, in an aqueous carrier, a lipid and a gas or gaseous precursor
Production of sterile formulation of drugs having low aqueous solubility involves filter sterilizing mixture of the drug and stabilizing agent in organic solvent having specific freezing temperature; then removal of solvent
Therapeutic applications of lipid-coated microbubbles
Ultrasonic Analysis of Peptide- and Antibody-Targeted Microbubble Contrast Agents for Molecular Imaging of α<SUB>v</SUB>β<SUB>3</SUB>-Expressing Cells
Formulation useful for treating e.g. cancer comprising camptothecin analog and stabilizing agent
Ultrasonic enhancement of alpha(v)beta(3) expressing-cells with targeted contrast agents
Pharmaceutical formulation useful for the treatment of e.g. cancer comprises a camptothecin analog and a stabilizing agent that does not bind covalently to the camptothecin analog
Polypeptide scaffold e.g. an avian pancreatic polypeptide that comprises modification by substitution of an amino acid residue, that is exposed on the alpha helix domain of the polypeptide is useful for screening for drugs
Targeting the dimerization interface for irreversible inhibition of HIV-1 protease
Selective amplification by auto- and cross-catalysis in a replicating peptide system
Missing publications? Search for publications with a matching author name.